Search
for
Sort by
Research 391–420 of 1000+
- The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19
- Management of Colorectal Cancer Using Nanocarriers-based Drug Delivery for Herbal Bioactives: Current and Emerging Approaches
- Trichomegaly of the eyelashes following treatment with cetuximab
- Pulmonary Edema in COVID-19 Patients: Mechanisms and Treatment Potential
- Effects of Subchronic Finasteride Treatment and Withdrawal on Neuroactive Steroid Levels and Their Receptors in the Male Rat Brain
- Herbal Therapy for the Treatment of Seborrhea Dermatitis
- Identifying SARS-CoV-2 entry inhibitors through drug repurposing screens of SARS-S and MERS-S pseudotyped particles
- Tailoring Risperidone-Loaded Glycethosomal In Situ Gels Using Box–Behnken Design for Treatment of Schizophrenia-Induced Rats via Intranasal Route
- Doxorubicin-induced hair loss in the Angora rabbit: a study of treatments to protect against the hair loss
- In vivo evaluation of the efficacy, toxicity and biodistribution of PLGA-DMSA nanoparticles loaded with itraconazole for treatment of paracoccidioidomycosis
- Epidermal growth factor receptor/mitogen-activated kinase inhibitor treatment induces a distinct inflammatory hair follicle response that includes collapse of immune privilege
- Use of Lasers in the Treatment of Alopecia Areata
- Lichenoid eruption and alopecia associated with captopril treatment
- An update on the treatment of female alopecia and the introduction of a potential novel therapy
- Repurposing existing drugs for the treatment ofCOVID-19/SARS-CoV-2: A review of pharmacological effects and mechanism of action
- Hair loss after drug reaction with eosinophilia and systemic symptoms (DRESS): A multicentric retrospective case series
- An urticarial drug eruption caused by tofacitinib for alopecia universalis
- Severe Pustular Drug Eruptions From Amivantamab: A Case Series
- Data-driven strategies for drug repurposing: insights, recommendations, and case studies
- Episodes of Keratitis during Treatment with Baricitinib for Alopecia Areata
- Disease modifying osteoarthritis drug discovery using a temporal phenotypic reporter in 3D aggregates of primary human chondrocytes
- Perspective Chapter: Repurposing Natural Products to Target COVID-19 – Molecular Targets and New Avenues for Drug Discovery
- Chemotherapy and Cutaneous Drug Reactions
- In Silico Structure-Based Drug Design Approach To Evaluate Quercetin And Kaempferol As Dual Inhibitors Of Jak3 Kinase And 5-Alpha Reductase Type II with ADMET Profiling
- In Silico Structure-Based Drug Design Approach To Evaluate Quercetin And Kaempferol As Dual Inhibitors Of Jak3 Kinase And 5-Alpha Reductase Type II with ADMET Profiling
- Green Nanodrugs: Research Progress and Challenges of Plant-Derived Nanovesicles in Tumor Treatment
- Combined Regenerative Technique: Tattoo Machine–Assisted Drug Delivery for Androgenetic Alopecia
- The Application Progress of Tumor Microenvironment-Responsive Drug Carriers in Precision Chemotherapy
- Cutaneous adverse drug reaction associated with topical use of benzyl benzoate in a dog
- Enhanced hair follicle accumulation and androgenetic alopecia treatment of finasteride by topical nanoparticles hydrogel system